Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details 5)

v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Details 5) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Convertible notes and accrued interest    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7,604,302 7,535,173
Convertible preferred stock - Series B    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 0 0
Stock options and warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 46,353,950 19,567,360